Analytik Jena Announces Forecast for 2011/2012 Financial Year

Jena, April 24, 2012 — Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) expects another sales and earnings increase for the current financial year 2011/2012. The Company forecasts consolidated sales of approximately EUR 91.0 m to EUR 93.0 m. Analytik Jena wants to achieve more than EUR 6.0 m in operating profit (EBIT) at the end of the period. In the 2010/2011 financial year, the Company generated consolidated sales of EUR 86.3 m as well as EBIT of EUR 5.0 m.

“Overall, we are satisfied with business in the first half of the year. We managed to make up for the weaker performance of the first quarter and have clearly exceeded the previous year’s level already half-way through the year. Improving business in Japan contributed particularly to this. We anticipate a continuation of this in the second half of the year,” said Klaus Berka, CEO of Analytik Jena AG.

Analytik Jena expects all three segments to contribute to the growth in sales and earnings. In particular, Life Science and Optics, the two divisions still in a weaker position, must make clear gains in the second half of the year in order to achieve this objective. In Life Science, the Company anticipates that the efforts in international sales development, particularly in China and the Arab countries, will pay off with the new regional office in Dubai. In Optics, the Company can point to a high order volume in the core business and in OEM products.

In the most important division, Analytical Instrumentation, Analytik Jena anticipates a continuation of the current very positive development. The Company expects a clear sales increase in the Japanese market – especially with the new product line of X-ray fluorescence equipment.

The Company is set to announce the complete figures for the second quarter and for the first six months of 2011/2012 on May 10, 2012.